Worldwide, many millions of individuals are at risk of blood pressure-related diseases such as stroke and coronary heart disease. The aim of the Blood Pressure Lowering Treatment Trialists’ Collaboration is to provide clinicians and their patients with the most reliable evidence possible about the effects of different classes of blood pressure lowering drugs and different blood pressure lowering regimens on cardiovascular morbidity and mortality in a variety of patient groups.